Anti nosebleeds effect of Achillia ointment
Phase 3
Completed
- Conditions
- Epistaxis.??????? ????
- Registration Number
- IRCT201410303186N6
- Lead Sponsor
- Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion critria: the patients who referred to the clinic of Besat hospital with recurrent epistaxis (minimum of 3 times per 2 months) and no specific etiology detect on history and physical exam
Exclusion criteria:
1- Age under 12 and above 50 years old.
2- Pregnancy.
3- OCP use.
4- Hx of ischemic heart disease.
5- Hx of hypertension.
6- Hx of thromboamboli.
7- Hx of allergy to Achillia
8- Coagulation disorder.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: Day 11th, fisrt month and third month after drug administration. Method of measurement: Epistaxis Severity score.
- Secondary Outcome Measures
Name Time Method Adverse effect. Timepoint: Day 11th, first month and third month after drug administration. Method of measurement: History and clinical examination.